STOCK TITAN

Appyea Stock Price, News & Analysis

APYP OTC

Welcome to our dedicated page for Appyea news (Ticker: APYP), a resource for investors and traders seeking the latest updates and insights on Appyea stock.

AppYea, Inc. (APYP) combines mobile technology expertise with advanced health solutions through its AI-powered wearable devices and sleep management systems. This news hub provides investors and industry observers with essential updates on corporate developments, product innovations, and market positioning.

Access timely announcements including financial results, technology patents, and strategic partnerships. Track progress in sleep apnea management through updates on AppySleep's clinical testing phases and user adoption metrics. Receive alerts about new mobile application launches across gaming, finance, and lifestyle sectors.

Our curated news collection serves as a definitive resource for understanding AppYea's dual focus on healthtech innovation and cross-platform app development. Monitor regulatory milestones, intellectual property expansions, and consumer adoption trends through verified press releases and objective reporting.

Bookmark this page for streamlined access to APYP's evolving story in wearable medical technology and competitive mobile solutions. Check regularly for updates on sensor technology advancements and market expansion initiatives shaping the future of sleep wellness tech.

Rhea-AI Summary

AppYea (OTCQB: APYP) has provided an update on its TechLott blockchain results engine development, confirming it remains on schedule for Q4 2025 completion. The platform is designed as a game-agnostic infrastructure layer supporting multiple applications including gaming, virtual horse racing, and sweepstakes.

The TechLott engine features provably fair results, on-chain receipts, multi-chain support (including Coinbase's Base L2), and developer-friendly integration through API/SDK. The system is built with compliance in mind, offering built-in audit and reporting capabilities for operator oversight and jurisdictional requirements.

Following the Q4 2025 completion milestone, AppYea plans to advance commercial integrations with operators as its next execution phase.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.37%
Tags
none
-
Rhea-AI Summary

AppYea (OTCQB: APYP) has announced a live investor briefing scheduled for September 16, 2025, where newly appointed CEO Yakir Abadi will present the company's commercial strategy following its recent Techlott platform acquisition. The briefing will detail the company's deployment roadmap and expanded gaming capabilities.

The Techlott platform, which has successfully completed over 212,000 test transactions, addresses key challenges in lottery operations through blockchain technology, offering verifiable draw engines and enhanced audit controls. The platform extends beyond traditional lottery to include number-draw formats, instant-win experiences, and raffle games, all built with comprehensive operator tools for responsible gaming.

The presentation will cover sales strategy, commercial model, deployment plans, platform readiness, and balance sheet execution. Management will also reveal a new program aligned with the initial rollout timeline to provide clarity on near-term commercial expectations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.58%
Tags
management conferences
-
Rhea-AI Summary

AppYea Inc. (OTCQB:APYP) has announced a strategic acquisition of Techlott Ltd.'s blockchain-based lottery and gaming platform, marking a significant business pivot. The platform features on-chain draw logic, verifiable randomness, and automated workflows, projecting substantial operational cost reductions for partners.

The global lottery market is valued at $353.29B (2024) and expected to reach $483.93B by 2030, with only 16% of activity currently online. The acquisition positions AppYea to capture this digital transformation opportunity. As part of the deal, Techlott becomes a significant shareholder with board representation, and AppYea plans to pursue an uplisting to a major US exchange.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.32%
Tags
Rhea-AI Summary

AppYea (OTCQB: APYP) has announced significant leadership changes with the appointment of Yakir Abadi as CEO and Director, alongside Eldar Edmond Grady as Executive Chairman of the Board. Abadi, recognized as one of Israel's leading fintech and blockchain entrepreneurs, brings extensive experience in digital banking, blockchain solutions, and cryptocurrency investments.

Grady joins as Executive Chairman, bringing valuable experience as owner of an international holding company that consults for NASDAQ-listed corporations and operates a leading PPLI wealth management agency. Former CEO Boris Molchadsky will remain as a director, expressing confidence in the new leadership team's ability to drive shareholder value.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.11%
Tags
none
-
Rhea-AI Summary

AppYea Inc. (OTCQB: APYP) has launched AppySleep, an innovative wearable solution to address snoring and monitor sleep apnea. The device consists of a smart biofeedback-based wristband that connects to an app on iPhone or Android. It detects snoring and activates gentle vibrations to prompt users to change their sleeping position.

Key features include:

  • AI-powered customization of snoring treatment
  • Detection of irregular breathing patterns
  • Personal cloud access for sleep history and statistics
  • Introductory price of $149

AppYea is also developing AppySleep LAB, a touchless app for diagnosing sleep apnea without overnight lab stays. The company plans to pre-submit an FDA request for AppySleep LAB in H1 2025. Market projections indicate significant growth potential in the sleep tech and anti-snoring treatment sectors.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.31%
Tags
none
-
Rhea-AI Summary

AppYea's Chairman Bary Molchadsky has converted approximately $140,000 of his debt into company warrants, with a strike price of $0.07 per share, reflecting a 250% premium over the current market price. This move demonstrates his confidence in the company's prospects. AppYea has recently started commercial deliveries of its AppySleep product in the U.S. and launched a new direct sales website and an Amazon store. The AppySleep wristband, a smart wearable for monitoring and treating sleep apnea and snoring, integrates with a smartphone app to improve sleep quality.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-33.74%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.57%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
18%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.92%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.49%
Tags
none

FAQ

What is the current stock price of Appyea (APYP)?

The current stock price of Appyea (APYP) is $0.028 as of September 17, 2025.

What is the market cap of Appyea (APYP)?

The market cap of Appyea (APYP) is approximately 16.8M.
Appyea

OTC:APYP

APYP Rankings

APYP Stock Data

16.75M
332.87M
37.75%
Software - Application
Technology
Link
Israel
Gan Yavne